Economic and Quality of Life Outcomes for Patients on ART in Kenya

Project Description

Studies investigating the impacts of ART on patients’ economic activities, quality of life, and other non-biomedical outcomes during the first year on treatment have consistently reported rapid and relatively large improvements in quality of life and/or work attendance during the first year on ART among adult patients in Africa.

Through a longitudinal study in Kenya, the CGHD is contributing to the understanding of the broader impacts of ART on individuals and households beyond the direct reduction of morbidity and mortality. The primary objectives of this study are to estimate the impact of HIV/AIDS on quality-of-life and labor-force participation indicators in the period prior to beginning ART and to estimate the impact of ART on these same indicators. We have identified sustained improvements in economic and quality of life outcomes which are likely to support long-term adherence to ART treatment and mitigate some of the negative economic and social consequences of untreated HIV/AIDS in high-prevalence countries.

This project is an activity under the CGHD’s ISHED: International Studies in Health and Economic Development.

Project Details

Principal Investigator Bruce Larson
Boston University Co-Investigators Matthew FoxSydney RosenJonathon Simon
Collaborators
  • Doug Shaffer
  • Fred Sawe
  • Margaret Bii, Kenya Medical Research Institute (KEMRI)
  • Walter Reed Project
Country(ies) Kenya
Dates of Research 2004–2010
Donor/Funder NIH_Logo_150National Institutes of Health (NIH)